<!DOCTYPE html>
<html>
<head>
  <meta charset="utf-8">
  <title>Institutional investors in Edwards Lifesciences Corporation (NYSE:EW) see US$1.5b decrease in market cap last week, although long-term gains have benefitted them.</title>
</head>
<body>
  <a href="../../index.html">← Back to home</a>
  <h1>Institutional investors in Edwards Lifesciences Corporation (NYSE:EW) see US$1.5b decrease in market cap last week, although long-term gains have benefitted them.</h1>
  <ul>
<li>Though their holding amounts to less than 1%, we can see that board members collectively own US$418m worth of shares (at current prices).</li>
<li>is currently the largest shareholder, with 12% of shares outstanding.</li>
<li>Still, the 12% one-year gains may have helped mitigate their overall losses.</li>
<li>And the group that holds the biggest piece of the pie are institutions with 88% ownership.</li>
<li>In comparison, the second and third largest shareholders hold about 9.5% and 4.4% of the stock.</li>
<li>Our data suggests that insiders own under 1% of Edwards Lifesciences Corporation in their own names.</li>
<li>Institutional investors own over 50% of the company, so together than can probably strongly influence board decisions.</li>
</ul>
<p><a href="https://finance.yahoo.com/news/institutional-investors-edwards-lifesciences-corporation-123030109.html">Source</a> · 2025-09-15T12:30:30+00:00</p>
</body>
</html>